Zantac’s Developer Settles Lawsuits Claiming Cancer Link
GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.
U.S. Races to Replace IV Fluid Supplies After Hurricane Helene
Officials are looking to foreign sources to ease shortages of IV bags caused by Hurricane Helene as hospitals begin rationing fluids to protect the sickest patients.
Mi pesadilla con el virus del Nilo Occidental
A medida que el cambio climático facilita la proliferación de mosquitos en muchos lugares, la enfermedad del virus del Nilo Occidental se perfila como una de las mayores amenazas de salud.
On Drug Prices, Harris Pushes for Deeper Cuts While Trump Offers Few Specifics
Both have campaigned for lower prescription costs. Kamala Harris has promised to expand President Biden’s policies. Donald Trump is a wild card.
Anthony Fauci: My West Nile Virus Nightmare
What it’s like to get the neglected disease.
How Cannabis and Opium Poppies Became National Security Issues
After supply chain disruptions that made critical medicines scarce, a federal effort is underway to ensure domestic stocks of pharmaceutical ingredients.
Mounjaro and Zepbound Are No Longer in Shortage, F.D.A. Says
The announcement will expand access to the diabetes and weight-loss drugs. But it will also complicate the future of compounded versions of the medications.
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries
Many middle-income countries are left out of the deal, widening a gulf in access to critical medicines.
Officials Cast Doubt on a Dementia Drug, but Human Trials Continue
The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.
International Ring Sent Fake Fentanyl and Other Deadly Pills From NYC, US Says
The drugs, which resembled real pharmaceuticals, killed nine people, prosecutors said. They were laced with fentanyl and methamphetamine.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.